Dear friend Wafa Sorfina

I hope this message finds you well! I wanted to share some important considerations regarding your work with silver nanoparticles in topical gel formulations, particularly concerning the use of AgNO₃ (silver nitrate). Understanding these factors can significantly impact the efficacy and safety of your product.

Firstly, safety and toxicity are paramount. It's crucial to assess the individual and combined effects of silver nanoparticles, especially when mixed with other ingredients like your marine-based extract and Carbopol 940. Given that AgNO₃ can be toxic, ensuring that its use as a precursor does not compromise safety is essential.

Next, consider the stability and compatibility of silver nanoparticles within your formulation. You’ll want to ensure that they maintain their effectiveness without reacting adversely with other components. Additionally, evaluating the concentration and size of the nanoparticles is vital for achieving the desired therapeutic action against oral ulcers without causing irritation.

Moreover, the method of incorporating the nanoparticles into the gel should be carefully planned to ensure even distribution, which is key for consistent efficacy. Lastly, don’t forget to review any regulatory guidelines regarding the use of silver nanoparticles in topical applications to ensure compliance with safety standards.

As you evaluate your formulations, remember that even if AgNO₃ isn't in the final product, understanding its role in synthesizing nanoparticles is beneficial. Thorough initial evaluations will pave the way for reliable in vivo testing later on. Best of luck with your formulation, and feel free to reach out if you have any questions or need further assistance!

Interesting to read: Chapter Synthesis Of Manganese Oxide Nanoparticles Using Similar Pro...

Warm regards,

Kaushik

Hi Kaushik, thank you for your explanation. I appreciate it. In my case, to address safety and toxicity concerns regarding AgNO₃, I will be using a green biosynthesis approach for AgNPs, which is more eco-friendly and biocompatible.

Hi!

Yes, evaluation of residual AgNO₃ (silver nitrate) is essential when it is used as a precursor in the synthesis of silver nanoparticles (AgNPs) for topical gel formulations, as unreacted AgNO₃ can pose toxicity and skin irritation risks due to its oxidative and ionic silver content. While AgNPs themselves exhibit controlled antimicrobial activity, free Ag⁺ ions from residual AgNO₃ can penetrate the skin more readily, leading to potential cytotoxicity. Regulatory guidelines (e.g., by FDA or EMA) emphasize the need for purity and safety of nanoparticle-based formulations, especially for dermal applications. Analytical techniques such as ion chromatography, ICP-MS (Inductively Coupled Plasma Mass Spectrometry), or UV-visible spectroscopy (after appropriate complexation) should be used to quantify and confirm the complete reduction or removal of AgNO₃. Furthermore, proper washing, dialysis, or centrifugation steps must be incorporated during nanoparticle preparation to minimize residual nitrate and ionic silver content before gel incorporation. Thus, evaluation of AgNO₃ is not only scientifically necessary but also critical for regulatory compliance and product safety.